PICH deficiency attenuates the progression of lung adenocarcinoma and disrupts the DNA damage response

Clin Transl Med. 2025 May;15(5):e70349. doi: 10.1002/ctm2.70349.

Li Miao¹, Lu Weina², Lou Jiafei¹, Chen Gaoying^{1

3

4}, Yu Yinghui¹, Wu Yinfang¹, Li Fei¹, Zhang Chao¹, Tang Haoyu^{1

3

4}, Weng Qingyu¹, Zheng Kua¹, Gao Shenwei¹, Wu Yanping¹, Zhu Chen¹, Zhang Min¹, Yu Fangyi¹, Jin Rui¹, Chen Zhihua¹, Geng Xinwei^{1

3

4}, Ying Songmin^{1

3

4}, Li Wen¹

¹ Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
² Surgical Intensive Care Unit, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
³ Department of Pharmacy, Center for Regeneration and Aging Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Yiwu, China.
⁴ Zhejiang-Denmark Joint Laboratory of Regeneration and Aging Medicine, Yiwu, Zhejiang, China.

No abstract available

Grants and funding